文献速递免疫规划传染病防控与疫情报告

苏格兰引入单价轮状病毒疫苗后轮状病毒感染分子流行病学变化

Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.
PubMed 文献 · Vaccine · 2016-11-18

该实验室监测研究对苏格兰2012-2015年轮状病毒阳性粪便样本进行基因分型,比较疫苗接种前(2009-2013年)与接种后(2014-2015年)的毒株分布。结果显示轮状病毒感染年报告数减少74.4%(RR-3.95;95%CI 3.53-4.42,p<0.001),G1P[8]流行率从72.1%降至15%,接种后G2P[4]成为优势株(21.9%)。

要点

  • 接种后轮状病毒感染年报告数减少74.4%(RR-3.95;95%CI 3.53-4.42,p<0.001)。
  • G1P[8]流行率从接种前72.1%(95%CI 67.42-76.33)降至接种后15%(95%CI 11.38-19.79)。
  • 接种后G2P[4]为优势株(21.9%,95%CI 17.48-27.17),G9P[8]、G12P[8]、G3P[8]感染增加。

核心结论

  • 该实验室监测研究显示,苏格兰引入轮状病毒疫苗后,报告轮状病毒病例显著减少,且优势株构成从G1P[8]向G2P[4]转变。
  • 对报告病例子集的基因分型数据将用于确定交叉保护及识别未来疫苗诱导的轮状病毒株变迁。

研究设计与样本

  • 实验室监测研究,对苏格兰病毒学实验室2012-2015年轮状病毒阳性粪便样本进行基因分型,并与疫苗接种前(2009-2013年)及接种后(2014-2015年)时期比较。

主要发现

  • 轮状病毒阳性样本从接种前(2009-2013年)的7409份降至2014-2015年的760份,年感染减少74.4%(RR-3.95;95%CI 3.53-4.42,p<0.001)。
  • 接种前362份和接种后278份样本进行了基因分型。
  • G1P[8]流行率从接种前72.1%(95%CI 67.42-76.33)降至接种后15%(95%CI 11.38-19.79)。
  • 接种后G2P[4]为苏格兰优势株(21.9%,95%CI 17.48-27.17),G9P[8](12.9%,95%CI 9.50-7.41)、G12P[8](12.2%,95%CI 8.89-16.60)和G3P[8](11.9%,95%CI 8.58-16.20)感染增加。
  • 接种前后G1P[8]株的VP7和VP4基因系统发育分析未显示重大差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 基因分型数据来自报告轮状病毒病例的子集。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rotaviruses (RV) are the leading cause of gastroenteritis in children less than five years of age worldwide. Rotarix®, a live attenuated monovalent vaccine containing a RV strain of G1P[8] specificity has been included in the childhood immunisation schedule from June 2013 in Scotland. This study aimed to characterise the prevalent RV strains in Scotland before and after the introduction of the RV vaccine. METHODS: RV positive faecal samples from Scottish virology laboratories covering the years 2012-2015 were genotyped. Viral RNA was extracted from faecal suspensions. VP7 and VP4 gene specific primers were used for multiplex hemi-nested PCRs and sequencing. Mann-Whitney U test and Chi-square test were used for statistical comparison. RESULTS: There was a decrease in RV positive samples from the Scottish virology laboratories from 7409 samples in the pre-vaccination years (2009-2013) to 760 in 2014-2015, with an annual reduction of RV infections by 74.4% (RR-3.95; 95%-CI, 3.53-4.42, p<0.001). 362 samples from the pre-vaccination period and 278 samples from the post-vaccination were genotyped. There was a drop in prevalence of G1P[8] strains (72.1%, 95%-CI, 67.42-76.33 to 15%, 95%-CI, 11.38-19.79) after introduction of the vaccine. In the post-vaccination period G2P[4] was the dominant strain in Scotland (21.9%, 95%-CI, 17.48-27.17) with increase in G9P[8] (12.9%, 95%-CI, 9.50-7.41), G12P[8] (12.2%, 95%-CI, 8.89-16.60) and G3P[8] (11.9%, 95%-CI, 8.58-16.20) infections. Phylogenetic analysis of the VP7 and VP4 genes showed no major differences between the pre and post-vaccination G1P[8] strains. CONCLUSION: This laboratory based surveillance study shows significant reduction in reported RV cases and a shift in proportion from G1P[8] to G2P[4] strains after introduction of RV vaccination in Scotland. The genotyping data from a subset of the total reported RV cases will be used to ascertain cross protection against strains and identify vaccine induced RV strain shifts in the years to come.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mukhopadhya I, Murdoch H, Berry S, et al. Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland. Vaccine. 2016. PMID: 27876201. doi:10.1016/j.vaccine.2016.11.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。